These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35372035)

  • 1. The Signaling Pathways Associated With Breast Cancer Bone Metastasis.
    Song X; Wei C; Li X
    Front Oncol; 2022; 12():855609. PubMed ID: 35372035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies.
    Wu X; Li F; Dang L; Liang C; Lu A; Zhang G
    Front Cell Dev Biol; 2020; 8():76. PubMed ID: 32117996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
    Chhichholiya Y; Ruthuparna M; Velagaleti H; Munshi A
    Clin Transl Oncol; 2023 May; 25(5):1218-1241. PubMed ID: 36897508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of breast cancer bone metastasis: a sequential multistep pattern.
    Fazilaty H; Mehdipour P
    Clin Exp Metastasis; 2014 Jun; 31(5):595-612. PubMed ID: 24493024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer.
    Jiang N; Hu Y; Wang M; Zhao Z; Li M
    Breast Cancer (Dove Med Press); 2022; 14():291-309. PubMed ID: 36193236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Runx2 and Its Signaling Pathways by MicroRNAs in Breast Cancer Metastasis.
    Pranavkrishna S; Sanjeev G; Akshaya RL; Rohini M; Selvamurugan N
    Curr Protein Pept Sci; 2021; 22(7):534-547. PubMed ID: 33200704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular signature of breast cancer metastasis to bone.
    Bahrami T; Mokmeli S; Hossieni H; Pourpaknia R; Makani Z; Salmaninejad A; Estiar MA; Hossieni A; Farshbaf A
    Anticancer Drugs; 2016 Oct; 27(9):824-31. PubMed ID: 27384592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANKLed by the Complexity of Signaling in Breast Cancer Metastasis to the Brain.
    Wang K; Hackney JR; Siegal GP; Wei S
    Clin Breast Cancer; 2020 Oct; 20(5):e569-e575. PubMed ID: 32381383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
    Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
    J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
    Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
    Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer.
    Wang Z; Li Z; Wu Q; Li C; Li J; Zhang Y; Wang C; Sun S; Sun S
    Cell Death Dis; 2020 Aug; 11(8):642. PubMed ID: 32811806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2.
    Ni X; Xia T; Zhao Y; Zhou W; Wu N; Liu X; Ding Q; Zha X; Sha J; Wang S
    Cancer Sci; 2014 Jan; 105(1):18-25. PubMed ID: 24164962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
    Shaker OG; Senousy MA
    Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review.
    Hinz N; Jücker M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling.
    Vella V; De Francesco EM; Lappano R; Muoio MG; Manzella L; Maggiolini M; Belfiore A
    Front Cell Dev Biol; 2020; 8():608412. PubMed ID: 33364239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models.
    Issa A; Gill JW; Heideman MR; Sahin O; Wiemann S; Dey JH; Hynes NE
    Breast Cancer Res; 2013 Jan; 15(1):R8. PubMed ID: 23343422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
    Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-135-5p inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by targeting SMAD3 in breast cancer.
    Yang W; Feng W; Wu F; Gao Y; Sun Q; Hu N; Lu W; Zhou J
    J Cancer; 2020; 11(21):6402-6412. PubMed ID: 33033523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.